Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Research & Development came in at $7.2 million in Q2 2026, up 5.52% year-over-year from $6.8 million in Q2 2025, and up 5.57% quarter-over-quarter from $6.8 million in Q1 2026.
Analysis
Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Research & Development for 7 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Research & Development rose 5.52% year-over-year to $7.2 million in Q2 2026; TTM through Jun 2026 was $29.8 million, a 13.03% increase from a year earlier, with the FY2025 full-year figure at $29.6 million, down 12.5% from the prior year.
- Research & Development was $7.2 million for Q2 2026 at Stevanato Group S.p.A, up from $6.8 million in the prior quarter.
- Over five years, Research & Development peaked at $11.7 million in Q1 2024 and troughed at $6.0 million in Q4 2024.
- A 5-year average of $8.4 million and a median of $8.8 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development gained 27.3% in 2024 and slumped 46.6% in 2025, its largest moves.
- Over 5 years, Research & Development stood at $10.8 million in 2022, then climbed by 0.48% to $10.9 million in 2023, then slumped by 44.93% to $6.0 million in 2024, then grew by 12.82% to $6.8 million in 2025, then gained by 6.95% to $7.2 million in 2026.
- The last three Research & Development figures came in at $7.2 million (Q2 2026), $6.8 million (Q1 2026), and $6.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 258.00 Mn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 19.70 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 129.00 Mn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 7.22 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 577,000.00 |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 1.53 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 3,852.00 |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.22 Mn |
| Mar 31, 2026 | 6.84 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 8.94 Mn |
| Jun 30, 2025 | 6.84 Mn |
| Mar 31, 2025 | 6.24 Mn |
| Dec 31, 2024 | 5.98 Mn |
| Sep 30, 2024 | 7.26 Mn |
| Jun 30, 2024 | 9.41 Mn |
| Mar 31, 2024 | 11.68 Mn |
| Dec 31, 2023 | 10.87 Mn |
| Sep 30, 2023 | 9.46 Mn |
| Jun 30, 2023 | 9.11 Mn |
| Mar 31, 2023 | 9.18 Mn |
| Dec 31, 2022 | 10.81 Mn |
| Sep 30, 2022 | 7.68 Mn |
| Jun 30, 2022 | 9.07 Mn |
| Mar 31, 2022 | 8.63 Mn |
| Dec 31, 2021 | 10.87 Mn |
| Sep 30, 2021 | 8.72 Mn |